Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$191.17 - $325.63 $191 - $325
-1 Reduced 0.03%
3,506 $1.14 Million
Q4 2023

Feb 13, 2024

BUY
$160.99 - $215.69 $232,147 - $311,024
1,442 Added 69.83%
3,507 $668,000
Q3 2023

Nov 14, 2023

BUY
$194.33 - $283.97 $45,667 - $66,732
235 Added 12.84%
2,065 $411,000
Q2 2023

Aug 11, 2023

SELL
$223.05 - $302.68 $252,046 - $342,028
-1,130 Reduced 38.18%
1,830 $522,000
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $517,634 - $643,081
2,951 Added 32788.89%
2,960 $641,000
Q4 2022

Feb 13, 2023

BUY
$204.38 - $296.82 $1,839 - $2,671
9 New
9 $1,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.